POZ - Latino Hub : Treatment News : HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking - by David Evans

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

February 18, 2010

HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

by David Evans

HIV infection increases the risk of developing lung cancer by about 80 percent, according to a study presented Wednesday, February 17, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. However, it is smoking among people living with HIV that poses the greatest risk of developing lung cancer.

Researchers have long known that people with HIV are more likely to get certain cancers, such as Kaposi’s sarcoma, especially when their CD4 cell counts drop. They are called AIDS-related cancers (ARC), and the rates of these opportunistic illnesses have fallen dramatically since the introduction of combination antiretroviral (ARV) therapy in the late 1990s.

Other cancers, such as lung cancer, have not traditionally been associated with HIV, but studies conducted during the past couple of years have indicated that people with HIV might be at increased risk of developing such cancers, especially as they live longer and contend with other disease risk factors.

To determine whether HIV adds to the risk of developing lung cancer, Keith Sigel, MD, MPH, from Mount Sinai School of Medicine in New York City and his colleagues examined the medical records of people receiving care through veterans administration (VA) clinics and hospitals. So that accurate rates of smoking history could be factored into the study—previous studies on lung cancer in HIV have not controlled for this aspect very well—Sigel’s team focused on veterans who had also filled out a 1999 survey on tobacco use.

In all, Sigel and his colleagues narrowed down a database of more than 100,000 veterans to 3,707 HIV-positive and 9,980 HIV-negative participants. The median follow-up was eight years. Basic characteristics between the two groups were similar. The median age of both groups was 47; many were non-white and 98 percent were male. With respect to smoking, the two groups differed somewhat. HIV-positive participants were more likely to smoke currently or to have quit smoking only recently.

There were just over 200 diagnosis of lung cancer in both groups combined during the follow-up period.

Sigel’s team found that HIV itself, after factoring out other characteristics such as smoking and age, was associated with an increased risk for developing lung cancer—an 80 percent increase in the relative risk compared with HIV-negative participants. Yet the increased risk associated solely with HIV infection was modest compared with smoking history. Current smokers and people who had quit within the past year were almost 10 times as likely to develop lung cancer as people who’d never smoked. People who’d quit more than one year earlier were just over five times as likely to develop lung cancer. People who reported smoking only occasionally were about 3.5 times more likely to develop lung cancer.

Interestingly, Hispanic participants were less likely to develop lung cancer than white or black participants, and the author commented that this has been found in several other studies.

Sigel acknowledged that they were not able to determine whether ARVs influenced the development of lung cancer. The rates of some types of cancers decrease when ARV therapy increases CD4 cells and controls viral replication.

Sigel stated that segmenting people into groups (such as non-smokers, occasional smokers, recently quit smokers and smokers who’d quit less recently) has been validated in other studies to produce a good assessment of a person’s lung cancer risk. He said, however, that determining the actual quantities of cigarettes a person has smoked recently, or ever, would have given an even more detailed picture of smoking’s influence on lung cancer risk.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 1 (of 1 total)    

Steve, Morristown, NJ, 2010-02-24 20:51:31
Scare tactics again. Read further. YET THE INCREASED RISK ASSOCIATED SOLELY WITH HIV INFECTION WAS MODEST COMPARED WITH SMOKING HISTORY. CURRENT SMOKERS AND PEOPLE WHO HAD QUIT WITHIN THE PAST YEAR WERE ALMOST 10 TIMES AS LIKELY TO DEVELOP LUNG CANCER AS PEOPLE WHO'D NEVER SMOKED. People who’d quit more than one year earlier were just over five times as likely to develop lung cancer. PEOPLE WHO REPORTED ONLY SMOKING OCCASIONALLY WERE ABOUT 3.5 TIMES MORE LIKELY TO DEVELOP LUNG CANCER. Enough!!

comments 1 - 1 (of 1 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.